EUVIMEDEUVIMED entdecken
Crossref

Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges

Yuting Wang, Peiran Chen, Ming-Liang He

Journal of Cellular Signaling · 2024

DOI: 10.33696/signaling.5.116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Signaling, 2024. Verfasst von Yuting Wang und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), although has faded from public view, the virus itself remains highly active and continues to mutate, continuously causing infections.

Zitieren

APA

Wang, Y., Chen, P., & He, M. (2024). Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges. Journal of Cellular Signaling. https://doi.org/10.33696/signaling.5.116

Vancouver

Wang Y, Chen P, He M. Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges. Journal of Cellular Signaling. 2024. doi:10.33696/signaling.5.116

BibTeX
@article{Wang2024,
  author = {Wang, Yuting and Chen, Peiran and He, Ming-Liang},
  title = {Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges},
  journal = {Journal of Cellular Signaling},
  year = {2024},
  doi = {10.33696/signaling.5.116}
}
Kostenlos starten →